Henri Doods

USPTO Granted Patents = 76 (Patent Applications = 14)

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 29 (Patent Applications = 34)

Average Co-Inventor Count = 7.4

ph-index = 11

Forward Citations = 573(Granted Patents)

Forward Citations (Not Self Cited) = 475(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Wathausen, DE (1991)
Warthausen, NL (2014 - 2015)
Ingelheim Am Rhein, DE (2019 - 2020)
Warthausen, DE (1991 - 2023)

Company Filing History:

41 out of 1,536

Boehringer Ingelheim International Gmbh

Centrexion Therapeutics Corporation

patents

4. 4 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

Boehringer Ingelheim Pharma Kg

9. 2 out of 832,843

Other

patents

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

CGRP Antagonists

Bradykinin B1-Antagonists

Somatostatin Receptor Agonists

1H-Benzimidazole-5-Carboxamides

Disubstituted Tetrahydrofuranyl Compounds

Pyrimidine Derivatives

Aryl Sulfonamides

Inhibitors of Microsomal Prostaglandin E2 Synthase

76 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12344601 - (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles (2025-07-01),

2. 11725004 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles (2023-08-15),

3. 11084810 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles (2021-08-10),

4. 10675268 - Somatostatin receptor subtype 4 (SSTR4) agonists (2020-06-09),

5. 10570125 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles (2020-02-25),

6. 10166214 - Somatostatin receptor subtype 4 (SSTR4) agonists (2019-01-01),

7. 10112934 - (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles (2018-10-30),

8. 9789082 - Somatostatin receptor subtype 4 (SSTR4) agonists (2017-10-17),

9. 9371282 - Somatostatin receptor subtype 4 (SSTR4) agonists (2016-06-21),

10. 9040565 - 1H-benzimidazole-5-carboxamides as anti-inflammatory agents (2015-05-26),

11. 8952014 - Pyrimidine derivatives which are CGRP—antagonists (2015-02-10),

12. 8951999 - Compounds (2015-02-10),

13. 8937073 - Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists (2015-01-20),

14. 8921405 - Compounds (2014-12-30),

15. 8916599 - 1H-benz imidazole-5-carboxamides as anti-inflammatory agents (2014-12-23),

Dear visitor, I have crafted an article about the innovative inventor Henri Doods, who stands as a beacon of inspiration in the world of inventions.

**Title: Henri Doods - A Trailblazer in the World of Inventions**

Introduction:

Henri Doods, a visionary inventor hailing from Warthausen, DE, is celebrated for his bold thinking and unwavering commitment to excellence in the realm of inventions.

Latest Patents:

Doods’ latest patents revolve around the groundbreaking (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles. These inventions focus on their use as CB2 cannabinoid receptor agonists, offering novel pharmaceutical compositions for the treatment of CB2 receptor mediated disorders or conditions.

Career Highlights:

With an impressive portfolio of 75 patents, Doods has consistently pushed the envelope of innovation. He has contributed significantly to the field, with each invention showcasing his dedication to pioneering advancements.

Collaborations:

Throughout his illustrious career, Doods has collaborated with esteemed companies such as Boehringer Ingelheim International GmbH and Dr. Karl Thomae GmbH. His work alongside notable coworkers like Klaus Rudolf and Stephan Georg Mueller has further solidified his reputation as a trailblazer.

Conclusion:

Henri Doods’ remarkable journey as an inventor serves as a testament to the power of passion, dedication, and visionary thinking in driving innovation forward. His legacy will continue to inspire future generations of inventors to dream big and make a lasting impact on the world of inventions.

If you have any more specific requests or need further information, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.